Fever-like hyperthermia controls T lymphocyte persistence by inducing degradation of cellular FLIPshort

Journal of Immunology

Volumn 178, Issue 6, 2007, Pages 3944-3953

  Meinander, Annika ^a   Söderström, Thomas S ^a   Kaunisto, Aara ^a,b   Poukkula, Minna ^a,b,c   Sistonen, Lea ^a   Eriksson, John E ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FLICE INHIBITORY PROTEIN; HEAT SHOCK PROTEIN 70; MESSENGER RNA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; FEVER; FLOW CYTOMETRY; HEAT STRESS; HUMAN; HUMAN CELL; HYPERTHERMIA; IMMUNE RESPONSE; IMMUNOBLOTTING; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN DEGRADATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UBIQUITINATION;

EID: 33947193429     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.6.3944     Document Type: Article

References (85)

1. Roberts, N. J., Jr. 1991. Impact of temperature elevation on immunologic defenses. Rev. Infect. Dis. 13: 462-472.
2. Kluger, M. J. 1991. Fever: role of pyrogens and cryogens. Physiol. Rev. 71: 93-127.
3. Hasday, J. D., and I. S. Singh. 2000. Fever and the heat shock response: distinct, partially overlapping processes. Cell Stress Chaperones 5: 471-480.
4. Jiang, Q., A. S. Cross, I. S. Singh, T. T. Chen, R. M. Viscardi, and J. D. Hasday. 2000. Febrile core temperature is essential for optimal host defense in bacterial peritonitis. Infect. Immun. 68: 1265-1270.
5. Ahlers, O., B. Hildebrandt, A. Dieing, M. Deja, T. Bohnke, P. Wust, H. Riess, H. Gerlach, and T. Kerner. 2005. Stress induced changes in lymphocyte subpopulations and associated cytokines during whole body hyperthermia of 41.8-42.2°C. Eur. J. Appl. Physiol. 95: 298-306.
6. Hammami, M. M., A. Bouchama, E. Shail, H. Y. Aboul-Enein, and S. Al-Sedairy. 1998. Lymphocyte subsets and adhesion molecules expression in heatstroke and heat stress. J. Appl. Physiol. 84: 1615-1621.
7. Hildebrandt, B., P. Wust, O. Ahlers, A. Dieing, G. Sreenivasa, T. Kerner, R. Felix, and H. Riess. 2002. The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol. Hematol. 43: 33-56.
8. Kida, Y., S. Tsuji-Kawahara, V. Ostapenko, S. Kinoshita, E. Kajiwara, H. Kawabata, T. Yuasa, I. Nishide, S. Yukawa, M. Ichinose, and M. Miyazawa. 2006. Increased liver temperature efficiently augments human cellular immune response: T-cell activation and possible monocyte translocation. Cancer Immunol. Immunother. 55: 1459-1469.
9. Lindquist, S. 1986. The heat-shock response. Annu. Rev. Biochem. 55: 1151-1191.
10. Morimoto, R. I. 1998. Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev. 12: 3788-3796.
11. Kerr, J. F., A. H. Wyllie, and A. R. Currie. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26: 239-257.
12. Danial, N. N., and S. J. Korsmeyer. 2004. Cell death: critical control points. Cell 116: 205-219.
13. Thorburn, A. 2004. Death receptor-induced cell killing. Cell. Signal. 16: 139-144.
14. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 370: 650-652.
15. Krammer, P. H. 2000. CD95's deadly mission in the immune system. Nature 407: 789-795.
16. Ashkenazi, A., and V. M. Dixit. 1998. Death receptors: signaling and modulation. Science 281: 1305-1308.
17. Lavrik, I., A. Golks, and P. H. Krammer. 2005. Death receptor signaling. J. Cell Sci. 118: 265-267.
18. Boldin, M. P., E. E. Varfolomeev, Z. Pancer, I. L. Mett, J. H. Camonis, and D. Wallach. 1995. A novel protein that interacts with the death domain of Fas/ APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270: 7795-7798.
19. Kischkel, F. C., S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P. H. Krammer, and M. E. Peter. 1995. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14: 5579-5588.
20. Boatright, K. M., M. Renatus, F. L. Scott, S. Sperandio, H. Shin, I. M. Pedersen, J. E. Ricci, W. A. Edris, D. P. Sutherlin, D. R. Green, and G. S. Salvesen. 2003. A unified model for apical caspase activation. Mol. Cell 11: 529-541.
21. Donepudi, M., A. Mac Sweeney, C. Briand, and M. G. Grutter. 2003. Insights into the regulatory mechanism for caspase-8 activation. Mol. Cell 11: 543-549.
22. Muzio, M., B. R. Stockwell, H. R. Stennicke, G. S. Salvesen, and V. M. Dixit. 1998. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273: 2926-2930.
23. Boatright, K. M., and G. S. Salvesen. 2003. Mechanisms of caspase activation. Curr. Opin. Cell Biol. 15: 725-731.
24. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, et al. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signaling complex. Cell 85: 817-827.
25. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J. L. Bodmer, M. Schroter, K. Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195.
26. Walsh, C. M., K. A. Luhrs, and A. F. Arechiga. 2003. The "fuzzy logic" of the death-inducing signaling complex in lymphocytes. J. Clin. Immunol. 23: 333-353.
27. Krueger, A., S. Baumann, P. H. Krammer, and S. Kirchhoff. 2001. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol. Cell. Biol. 21: 8247-8254.
28. Hietakangas, V., M. Poukkula, K. M. Heiskanen, J. T. Karvinen, L. Sistonen, and J. E. Eriksson. 2003. Erythroid differentiation sensitizes K562 leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP. Mol. Cell. Biol. 23: 1278-1291.
29. Krueger, A., I. Schmitz, S. Baumann, P. H. Krammer, and S. Kirchhoff. 2001. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem. 276: 20633-20640.
30. Micheau, O., M. Thome, P. Schneider, N. Holler, J. Tschopp, D. W. Nicholson, C. Briand, and M. G. Grutter. 2002. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 277: 45162-45171.
31. L. Biochem. J. 382: 651-657.
32. L is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 21: 3704-3714.
33. + T cell activation through caspase-8-dependent NF-κB activation. J. Immunol. 174: 5270-5278.
34. Kreuz, S., D. Siegmund, J. J. Rumpf, D. Samel, M. Leverkus, O. Janssen, G. Hacker, O. Dittrich-Breiholz, M. Kracht, P. Scheurich, and H. Wajant. 2004. NFκB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. J. Cell Biol. 166: 369-380.
35. Hu, W. H., H. Johnson, and H. B. Shu. 2000. Activation of NF-κB by FADD, Casper, and caspase-8. J. Biol. Chem. 275: 10838-10844.
36. Chaudhary, P. M., M. T. Eby, A. Jasmin, A. Kumar, L. Liu, and L. Hood. 2000. Activation of the NF-κB pathway by caspase 8 and its homologs. Oncogene 19: 4451-4460.
37. Kataoka, T., R. C. Budd, N. Holler, M. Thome, F. Martinon, M. Irmler, K. Burns, M. Hahne, N. Kennedy, M. Kovacsovics, and J. Tschopp. 2000. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Curr. Biol. 10: 640-648.
38. L processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-κB signaling pathway. Mol. Cell. Biol. 24: 2627-2636.
39. Peter, M. E. 2004. The flip side of FLIP. Biochem. J. 382: e1-e3.
40. Budd, R. C., W. C. Yeh, and J. Tschopp. 2006. cFLIP regulation of lymphocyte activation and development. Nat. Rev. Immunol. 6: 196-204.
41. Li-Weber, M., and P. H. Krammer. 2002. The death of a T-cell: expression of the CD95 ligand. Cell Death Differ. 9: 101-103.
42. Norian, L. A., K. M. Latinis, S. L. Eliason, K. Lyson, C. Yang, T. Ratliff, and G. A. Koretzky. 2000. The regulation of CD95 (Fas) ligand expression in primary T cells: induction of promoter activation in CD95LP-Luc transgenic mice. J. Immunol. 164: 4471-4480.
43. Fortner, K. A., and R. C. Budd. 2005. The death receptor Fas (CD95/APO-1) mediates the deletion of T lymphocytes undergoing homeostatic proliferation. J. Immunol. 175: 4374-4382.
44. Krueger, A., S. C. Fas, S. Baumann, and P. H. Krammer. 2003. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol. Rev. 193: 58-69.
45. Sharma, K., R. X. Wang, L. Y. Zhang, D. L. Yin, X. Y. Luo, J. C. Solomon, R. F. Jiang, K. Markos, W. Davidson, D. W. Scott, and Y. F. Shi. 2000. Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol. Ther. 88: 333-347.
46. Pinkoski, M. J., and D. R. Green. 1999. Fas ligand, death gene. Cell Death Differ. 6: 1174-1181.
47. Cippitelli, M., C. Fionda, D. Di Bona, M. Piccoli, L. Frati, and A. Santoni. 2005. Hyperthermia enhances CD95-ligand gene expression in T lymphocytes. J. Immunol. 174: 223-232.
48. Tran, S. E., A. Meinander, and J. E. Eriksson. 2004. Instant decisions: transcription-independent control of death-receptor-mediated apoptosis. Trends Biochem. Sci. 29: 601-608.
49. Söderström, T. S., M. Poukkula, T. H. Holmström, K. M. Heiskanen, and J. E. Eriksson. 2002. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8. J. Immunol. 169: 2851-2860.
50. Holmström, T. H., I. Schmitz, T. S. Söderström, M. Poukkula, V. L. Johnson, S. C. Chow, P. H. Krammer, and J. E. Eriksson. 2000. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. EMBO J. 19: 5418-5428.
51. Peter, M. E., F. C. Kischkel, C. G. Scheuerpflug, J. P. Medema, K. M. Debatin, and P. H. Krammer. 1997. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/ caspase 8) to the CD95 death-inducing signaling complex. Eur. J. Immunol. 27: 1207-1212.
52. Kirchhoff, S., W. W. Muller, A. Krueger, I. Schmitz, and P. H. Krammer. 2000. TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity. J. Immunol. 165: 6293-6300.
53. Schmitz, I., H. Weyd, A. Krueger, S. Baumann, S. C. Fas, P. H. Krammer, and S. Kirchhoff. 2004. Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort. J. Immunol. 172: 2194-2200.
54. Bosque, A., J. Pardo, M. J. Martinez-Lorenzo, M. Iturralde, I. Marzo, A. Pineiro, M. A. Alava, J. Naval, and A. Anel. 2005. Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c-FLIP, Bim, or Bcl-x isoform expression. J. Leukocyte Biol. 77: 568-578.
55. Zhang, N., and Y. W. He. 2005. An essential role for c-FLIP in the efficient development of mature T lymphocytes. J. Exp. Med. 202: 395-404.
56. Chau, H., V. Wong, N. J. Chen, H. L. Huang, W. J. Lin, C. Mirtsos, A. R. Elford, M. Bonnard, A. Wakeham, A. I. You-Ten, et al. 2005. Cellular FLICE-inhibitory protein is required for T cell survival and cycling. J. Exp. Med. 202: 405-413.
57. Sharief, M. K. 2000. Increased cellular expression of the caspase inhibitor FLIP in intrathecal lymphocytes from patients with multiple sclerosis. J. Neuroimmunol. 111: 203-209.
58. Semra, Y. K., O. A. Seidi, and M. K. Sharief. 2001. Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis. J. Neuroimmunol. 113: 268-274.
59. Catrina, A. I., A. K. Ulfgren, S. Lindblad, L. Grondal, and L. Klareskog. 2002. Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium. Ann. Rheum. Dis. 61: 934-936.
60. Panner, A., C. D. James, M. S. Berger, and R. O. Pieper. 2005. mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Mol. Cell. Biol. 25: 8809-8823.
61. Salon, C., B. Eymin, O. Micheau, L. Chaperot, J. Plumas, C. Brambilla, E. Brambilla, and S. Gazzeri. 2006. E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short). Cell Death Differ. 13: 260-272.
62. Tran, S. E., A. Meinander, T. H. Holmström, A. Rivero-Muller, K. M. Heiskanen, E. K. Linnau, M. J. Courtney, D. D. Mosser, L. Sistonen, and J. E. Eriksson. 2003. Heat stress downregulates FLIP and sensitizes cells to Fas receptor-mediated apoptosis. Cell Death Differ. 10: 1137-1147.
63. Poukkula, M., A. Kaunisto, V. Hietakangas, K. Denessiouk, T. Katajamäki, M. S. Johnson, L. Sistonen, and J. E. Eriksson. 2005. Rapid turnover of c-FLIP-short is determined by its unique C-terminal tail. J. Biol. Chem. 280: 27345-27355.
64. Scaffidi, C., I. Schmitz, P. H. Krammer, and M. E. Peter. 1999. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274: 1541-1548.
65. Kim, Y., N. Suh, M. Sporn, and J. C. Reed. 2002. An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis. J. Biol. Chem. 277: 22320-22329.
66. Perez, D., and E. White. 2003. E1A sensitizes cells to tumor necrosis factor α by downregulating c-FLIP S. J. Virol. 77: 2651-2662.
67. Chanvorachote, P., U. Nimmannit, L. Wang, C. Stehlik, B. Lu, N. Azad, and Y. Rojanasakul. 2005. Nitric oxide negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-proteasome-mediated degradation of FLICE inhibitory protein. J. Biol. Chem. 280: 42044-42050.
68. Zhang, S., H. M. Shen, and C. N. Ong. 2005. Down-regulation of c-FLIP contributes to the sensitization effect of 3,3′-diindolylmethane on TRAIL-induced apoptosis in cancer cells. Mol. Cancer Ther. 4: 1972-1981.
69. L turnover. Cell 124: 601-613.
70. Mosser, D. D., A. W. Caron, L. Bourget, C. Denis-Larose, and B. Massie. 1997. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol. Cell. Biol. 17: 5317-5327.
71. Ozoren, N., and W. El-Deiry. 2002. Heat shock protects HCT116 and H460 cells from TRAIL-induced apoptosis. Exp. Cell Res. 281: 175-181.
72. Gabai, V. L., K. Mabuchi, D. D. Mosser, and M. Y. Sherman. 2002. Hsp72 and stress kinase c-jun N-terminal kinase regulate the bid-dependent pathway in tumor necrosis factor-induced apoptosis. Mol. Cell. Biol. 22: 3415-3424.
73. Clemons, N. J., K. Buzzard, R. Steel, and R. L. Anderson. 2005. Hsp72 inhibits Fas-mediated apoptosis upstream of the mitochondria in type II cells. J. Biol. Chem. 280: 9005-9012.
74. Jäättelä, M., D. Wissing, P. A. Bauer, and G. C. Li. 1992. Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J. 11: 3507-3512.
75. Hobohm, U. 2001. Fever and cancer in perspective. Cancer Immunol. Immunother. 50: 391-396.
76. Wust, P., B. Hildebrandt, G. Sreenivasa, B. Rau, J. Gellermann, H. Riess, R. Felix, and P. M. Schlag. 2002. Hyperthermia in combined treatment of cancer. Lancet Oncol. 3: 487-497.
77. van der Zee, J. 2002. Heating the patient: a promising approach? Ann. Oncol. 13: 1173-1184.
78. Ganten, T. M., T. L. Haas, J. Sykora, H. Stahl, M. R. Sprick, S. C. Fas, A. Krueger, M. A. Weigand, A. Grosse-Wilde, W. Stremmel, et al. 2004. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Cell Death Differ. 11(Suppl. 1): S86-S96.
79. Tu, S., G. P. McStay, L. M. Boucher, T. Mak, H. M. Beere, and D. R. Green. 2006. In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis. Nat. Cell Biol. 8: 72-77.
80. Shin, S., Y. Lee, W. Kim, H. Ko, H. Choi, and K. Kim. 2005. Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8. EMBO J. 24: 3532-3542.
81. Pickart, C. M. 2001. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70: 503-533.
82. Dorion, S., and J. Landry. 2002. Activation of the mitogen-activated protein kinase pathways by heat shock. Cell Stress Chaperones 1: 200-206.
83. Su, H., N. Bidere, L. Zheng, A. Cubre, K. Sakai, J. Dale, L. Salmena, R. Hakem, S. Straus, and M. Lenardo. 2005. Requirement for caspase-8 in NF-κB activation by antigen receptor. Science 307: 1465-1468.
84. Bach, J. F. 2005. Six questions about the hygiene hypothesis. Cell. Immunol. 233: 158-161.
85. Yazdanbakhsh, M., P. G. Kremsner, and R. van Ree. 2002. Allergy, parasites, and the hygiene hypothesis. Science 296: 490-494.